Incidence and factors associated with cutaneous immune-related adverse events to immune check point inhibitors: An ambispective cohort study

MLA

Athitaya Luangnara, et al. “Incidence and Factors Associated with Cutaneous Immune-Related Adverse Events to Immune Check Point Inhibitors: An Ambispective Cohort Study.” Frontiers in Immunology, vol. 13, June 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....1f2ac6a78d0a13a4c3d2416005703880&authtype=sso&custid=ns315887.

APA

Athitaya Luangnara, Salin Kiratikanon, Thanika Ketpueak, Thatthan Suksombooncharoen, Chaiyut Charoentum, Busyamas Chewaskulyong, Napatra Tovanabutra, Siri Chiewchanvit, Surapon Nochaiwong, & Mati Chuamanochan. (2022). Incidence and factors associated with cutaneous immune-related adverse events to immune check point inhibitors: An ambispective cohort study. Frontiers in Immunology, 13.

Chicago

Athitaya Luangnara, Salin Kiratikanon, Thanika Ketpueak, Thatthan Suksombooncharoen, Chaiyut Charoentum, Busyamas Chewaskulyong, Napatra Tovanabutra, Siri Chiewchanvit, Surapon Nochaiwong, and Mati Chuamanochan. 2022. “Incidence and Factors Associated with Cutaneous Immune-Related Adverse Events to Immune Check Point Inhibitors: An Ambispective Cohort Study.” Frontiers in Immunology 13 (June). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....1f2ac6a78d0a13a4c3d2416005703880&authtype=sso&custid=ns315887.